R3R-01

N/A

Report date: 2023/04/04 14:50:53
NME

Base Information

Drug NameR3R-01
Drug Alias NameR3R-01R3R01R-3-R-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP binding cassette subfamily A member 1 stimulants
TargetsATP binding cassette subfamily A member 1
Therapy Area/IndicationsGlomerulosclerosis, Focal SegmentalDiabetic NephropathiesNephritis, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRiver 3 Renal Corp
China Registration ClassN/A

Develop Information

Active CompaniesRiver 3 Renal Corp
Inactive CompaniesN/A
Active IndicationsGlomerulosclerosis, Focal SegmentalDiabetic NephropathiesNephritis, Hereditary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A